Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q3 2016 · 10-Q
Revenue$162.32K$162.32K+274.6% vs Q3 2015 Net Income-$2.48M-$2.48MN/M vs Q3 2015 EPS Diluted-$0.03-$0.03N/M vs Q3 2015 Gross Profit$115,209+392.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,105,435N/M Margins · derivedGross margin71.0%+17.0 pt vs Q3 2015
Operating margin-755.1%+2929.8 pt vs Q3 2015
Net margin-1530.4%+2677.0 pt vs Q3 2015
ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end